United States · FDA National Drug Code directory

Cyclobenzaprine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63187-812_3afe19fb-b693-47f7-a08e-a46cc756ffda
Product NDC
63187-812
Form
TABLET, FILM COATED
Composition / generic term
Cyclobenzaprine
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20160722
Source listing expiry
20261231

Source-listed ingredients

  • CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 7 TABLET, FILM COATED in 1 BOTTLE (63187-812-07) · 63187-812-07
  • 10 TABLET, FILM COATED in 1 BOTTLE (63187-812-10) · 63187-812-10
  • 12 TABLET, FILM COATED in 1 BOTTLE (63187-812-12) · 63187-812-12
  • 15 TABLET, FILM COATED in 1 BOTTLE (63187-812-15) · 63187-812-15
  • 20 TABLET, FILM COATED in 1 BOTTLE (63187-812-20) · 63187-812-20
  • 21 TABLET, FILM COATED in 1 BOTTLE (63187-812-21) · 63187-812-21
  • 30 TABLET, FILM COATED in 1 BOTTLE (63187-812-30) · 63187-812-30
  • 45 TABLET, FILM COATED in 1 BOTTLE (63187-812-45) · 63187-812-45
  • 60 TABLET, FILM COATED in 1 BOTTLE (63187-812-60) · 63187-812-60
  • 120 TABLET, FILM COATED in 1 BOTTLE (63187-812-72) · 63187-812-72
  • 90 TABLET, FILM COATED in 1 BOTTLE (63187-812-90) · 63187-812-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →